Starget Pharma
Agent25Agent Readiness: 25/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Early-stage clinical company developing smart targeted radioligands for precision oncology.
About
Starget Pharma develops Smart Targeted Radioligands (STRs) for precision oncology of hard-to-heal cancers. Their AI-driven peptide-based discovery engine rapidly identifies radioligands that deliver high-energy radiation precisely to tumoral and metastatic cancer cells while sparing healthy tissues. This technology aims to accelerate the discovery and development of novel, targeted peptide radioligands for a broad range of cancers, offering new hope to patients.
Key facts
At-a-glance profile data
- Website
- stargetpharma.com
- Founded
- 2019
- Employees
- 21
- Total funding
- $15M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 28 Oct 2024 | Series B | $5M | - | Cancer Focus Fund |
| 30 Nov 2021 | Series A | $10M | $20M | Ilex Medical |
Tech stack
Detected on stargetpharma.com, last scanned 25 Jul 2026. Run your own scan
- Frontend
- Next.js
- CDN
- AWS CloudFront
- Hosting
- AWS
- Email provider
- Google Workspace
Frequently asked
How much funding has Starget Pharma raised?
Starget Pharma has raised a total of $15M in funding. The most recent round on record is Series B.
How many employees does Starget Pharma have?
Starget Pharma has approximately 21 people on record.
What is Starget Pharma's current status?
Starget Pharma's current operating status is: Inactive.